Volume 29, Issue 1 pp. 87-96
Original Research-Clinical Science

Functional recovery in human partial thickness skin wounds after application of multicomponent hydrolipidic film (MAS063DP): A prospective, open-label, comparative clinical trial

Erh-Ti Lin MD

Erh-Ti Lin MD

Department of Education, China Medical University Hospital, Taichung, Taiwan, Republic of China

Department of Orthopedics, China Medical University Hospital, Taichung, Taiwan, Republic of China

Search for more papers by this author
Bor-Shyh Lin PhD

Bor-Shyh Lin PhD

Institute of Imaging and Biomedical Photonics, National Chiao Tung University, Tainan, Taiwan, Republic of China

Search for more papers by this author
Li-Cheng Tsai MD

Li-Cheng Tsai MD

Department of Education, China Medical University Hospital, Taichung, Taiwan, Republic of China

Search for more papers by this author
Wei-Kung Chen MD

Wei-Kung Chen MD

Department of Emergency, China Medical University Hospital, Taichung, Taiwan, Republic of China

Search for more papers by this author
Yen-Jen Wang MD

Yen-Jen Wang MD

Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan, Republic of China

Search for more papers by this author
Hsiu-Mei Chiang PhD

Hsiu-Mei Chiang PhD

Department of Cosmeceutics and Graduate Institute of Cosmeceutics, China Medical University, Taichung, Taiwan, Republic of China

Search for more papers by this author
Chang-Cheng Chang MD, PhD

Corresponding Author

Chang-Cheng Chang MD, PhD

Aesthetic Medical Center, China Medical University Hospital, Taichung, Taiwan, Republic of China

Institute of Imaging and Biomedical Photonics, National Chiao Tung University, Tainan, Taiwan, Republic of China

Department of Cosmeceutics and Graduate Institute of Cosmeceutics, China Medical University, Taichung, Taiwan, Republic of China

Correspondence

Chang-Cheng Chang, Aesthetic Medical Center, China Medical University Hospital, Taichung, Taiwan, Republic of China

Email: [email protected]

Search for more papers by this author
First published: 12 October 2020

Funding information: China Medical University, Grant/Award Number: CMU106-ASIA-20; Menarini Asia-Pacific Holdings PTE LTD, Grant/Award Number: 10642692

Abstract

Acute and minor skin wounds are common in daily life. However, in clinical practice, after initial management in the acute phase, the wounds are managed mainly through observation, and the patients are usually lost to follow-up. Considering a multicomponent hydrolipidic dressing (MAS063DP) long-known for its safe application in eczema and recently in laser-induced wounds, we aimed to evaluate its ability in functional recovery of impaired skin integrity during wound healing. Sixteen patients (N = 16) were enrolled and completed (n = 8 vs n = 8) this prospective, open-label, vehicle-controlled clinical trial with 12-week follow-up. Transepidermal water, skin viscoelasticity and bioimpedance analysis were measured initially, at the 1st, 4th, 8th, and 12th weeks. Improvements in these parameters were greater in the MAS063DP group (from 31.4 ± 9.0 to 16.4 ± 4.3 g/m2 h, P < .001; from 77 ± 16% to 88 ± 9%, P < .05; from 4182 ± 3823 to 2644 ± 1772 Ω) than in the white petrolatum group. No significant adverse events occurred, and all participants were more satisfied with the intervention. In this study, MAS063DP can restore skin integrity and reinstitute physiologic function as a feasible and safe intervention more markedly than management through observation during the healing process by providing protective hydrolipidic layer on the skin with simultaneous anti-inflammatory and antioxidant activities from its key ingredients such as glycyrrhetinic acid, Vitis vinifera, telmesteine, and vitamins C and E.

CONFLICT OF INTEREST

The authors declare no conflicts of interest relevant to the reported work.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.